52-Week Performance Chart

Powered by FactSet Research Systems Inc

Recent Company News

More

No news is available

Powered by FactSet Research Systems Inc.

No DR Special Notices are available.

No DR Events are available.

Data provided by Thomson Reuters

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
HOPPE & SCHULTZ AG 23,000
Templeton Asset Management Ltd. 21,616
Aviva Investors Global Services Ltd. 13,200
TOP MUTUAL FUND HOLDERS POSITION
No Data Available N/A

Data provided by FactSet Research Systems Inc.

DR Details

DR Symbol HYPMY
CUSIP 44914U106
DR Venue OTC
DR ISIN US44914U1060
Ratio DR:ORD 1:1
Underlying ISIN BRHYPEACNOR0
Country Brazil
Effective Date May 04, 2020
Depositary CIT (Sponsored)
Industry Food Producers
Hypera is a pharmaceutical company. Under the umbrella brand Mantecorp Farmasa; the Company operates in various medical areas within the Primary Care segment, including several products in Brazil, including Predsim, Celestamine, Maxsulid, Diprospan, Mioflex-A and Addera D3. Under the brand Mantecorp Skincare, it provides dermo-cosmetics recommended by dermatologists throughout Brazil. The Company is a supplier in the Brazilian market of prescription-free products, including brands such as Apracur, Benegrip, Coristina d, Engov, Epocler and Estomazil, among others. It also provides nutrition, sweeteners and vitamin supplement lines, with brands such as Tamarine, Vitasay 50+, Biotônico Fontoura and Zero-Cal. 

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Jun.25 4.83 1,076,429 53,821
May.25 4.44 92,909 4,424
Apr.25 3.71 116,687 5,557

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE